Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018

Blood. 2021 May 20;137(20):2848-2851. doi: 10.1182/blood.2020009552.

D E Issa^{1

2}, R L Seefat¹, O Visser³, S Zweegman², P J Lugtenburg⁴, A G Dinmohamed^{1

5

6}, M E D Chamuleau¹

¹ Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU Medical Center, Amsterdam, The Netherlands.
² Department of Hematology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
³ Department of Registration, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.
⁴ Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁵ Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands; and.
⁶ Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

No abstract available

Publication types